Halozyme Therapeutics Beats Q4 Views; Outlook Shy Of Consensus By: Benzinga via Benzinga March 02, 2015 at 18:59 PM EST Halozyme Therapeutics, Inc. (NASDAQ: HALO) posted better-than expected fourth quarter results on Monday, but offered a revenue forecast ... Read More >> Related Stocks: Halozyme Therapeutic